NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $569,653 | -1.5% | 5,593 | -2.4% | 0.11% | -0.9% |
| Q2 2023 | $578,215 | -2.6% | 5,730 | -11.2% | 0.11% | -4.5% |
| Q1 2023 | $593,861 | -9.8% | 6,455 | -11.0% | 0.11% | -15.8% |
| Q4 2022 | $658,175 | +17.7% | 7,255 | -1.4% | 0.13% | -0.7% |
| Q3 2022 | $559,000 | -10.1% | 7,359 | +0.1% | 0.13% | -7.6% |
| Q2 2022 | $622,000 | -47.6% | 7,355 | -45.6% | 0.14% | -38.8% |
| Q1 2022 | $1,187,000 | +1.0% | 13,528 | +0.7% | 0.24% | -6.0% |
| Q4 2021 | $1,175,000 | -10.5% | 13,428 | -16.4% | 0.25% | -45.7% |
| Q3 2021 | $1,313,000 | -16.5% | 16,056 | -6.8% | 0.46% | +23.7% |
| Q2 2021 | $1,572,000 | -6.6% | 17,227 | -85.6% | 0.38% | -9.4% |
| Q1 2021 | $1,683,000 | -66.1% | 119,438 | -24.3% | 0.41% | -71.8% |
| Q4 2020 | $4,964,000 | – | 157,675 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |